Aspirin underuse in secondary prevention: beyond access and adherence
Global Cardiology · 19.06.2026 · 4 (2)
DOI: 10.4081/cardio.2026.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Cardiology, online erschienen am 19.06.2026. Verfasst von Fasih Mehmood und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
To the Editor, Cardiovascular disease remains the leading cause of mortality worldwide, yet aspirin, one of the most effective and inexpensive therapies for secondary prevention, continues to be underused across diverse healthcare settings and patient populations. Importantly, this underuse reflects not only limited access to therapy, but also disparities in adherence, persistence, and uncertainty regarding benefit in certain high-risk groups [...]
Zitieren
APA
Mehmood, F., Magsi, N., & Tariq, A. (2026). Aspirin underuse in secondary prevention: beyond access and adherence. Global Cardiology, 4(2). https://doi.org/10.4081/cardio.2026.105
Vancouver
Mehmood F, Magsi N, Tariq A. Aspirin underuse in secondary prevention: beyond access and adherence. Global Cardiology. 2026;4(2). doi:10.4081/cardio.2026.105
BibTeX
@article{Mehmood2026,
author = {Mehmood, Fasih and Magsi, Nayab and Tariq, Arslan},
title = {Aspirin underuse in secondary prevention: beyond access and adherence},
journal = {Global Cardiology},
year = {2026},
volume = {4},
number = {2},
doi = {10.4081/cardio.2026.105}
}
EUVIMED